Waterpipe smoking: Results from a population-based study in Qatar.

Qatar prevalence smoking tobacco waterpipe

Journal

Tobacco induced diseases
ISSN: 1617-9625
Titre abrégé: Tob Induc Dis
Pays: Greece
ID NLM: 101201591

Informations de publication

Date de publication:
2022
Historique:
received: 02 02 2022
revised: 06 04 2022
accepted: 09 05 2022
entrez: 15 7 2022
pubmed: 16 7 2022
medline: 16 7 2022
Statut: epublish

Résumé

Waterpipe smoking is common in the Eastern Mediterranean Region and is becoming more prevalent in Qatar. To better plan waterpipe smoking control strategies we aimed to: 1) determine the prevalence of waterpipe smoking and explore its patterns in Qatar; 2) describe the knowledge, attitudes, and practices related to smoking behaviors; 3) recognize locations of waterpipe smoking and symptoms experienced during waterpipe sessions; and 4) evaluate the frequency of waterpipe smoking and the initiation age. We analyzed the data of a 7921 population-based survey of adults aged ≥18 years (nationals and expatriates), conducted in Qatar between March and December 2019. Out of 7105 surveys collected, 6904 were complete and included in the analysis. Of the 6904, 570 (8.3%; 95% CI: 7.7-9.0) were waterpipe tobacco smokers, 425 (10.6%) males and 145 (5.1%) females. The highest prevalence of waterpipe smoking was reported among people aged 18-24 years (10.6%). Of the 575 waterpipe smokers, 56.3% (n=324) were exclusive waterpipe smokers. Use of other tobacco products among waterpipe smokers was higher among Qataris (52.3%) than expatriates (37.7%). Waterpipe cafés were the most common location for waterpipe smoking, however, females preferred restaurants; 83.3% reported that waterpipe smoking is harmful, while 39.3% considered that it is less harmful than cigarette smoking. Waterpipe smoking prevalence is considerably high in Qatar, the second form of tobacco used. The formulation of new policies and enforcement of regulatory restrictions on waterpipe smoking are essential to reduce its uptake. Expansion in tobacco cessation services for women and poly-tobacco users is needed.

Identifiants

pubmed: 35836909
doi: 10.18332/tid/149907
pii: 61
pmc: PMC9227603
doi:

Types de publication

Journal Article

Langues

eng

Pagination

61

Informations de copyright

© 2022 AlMulla A. et al.

Déclaration de conflit d'intérêts

The authors have each completed and submitted an ICMJE form for disclosure of potential conflicts of interest. The authors declare that they have no competing interests, financial or otherwise, related to the current work. A. AlMulla and S. Kouyoumjian, report that since the initial planning of the work this research was supported by the Medical Research Center in Hamad Medical Corporation Doha-Qatar (MRC-Routine grant 01-17-073). Open Access publication funding was provided by the Qatar National Library.

Références

J Smok Cessat. 2021 Feb 3;2021:6632379
pubmed: 34306226
Tob Control. 2015 Oct;24(e3):e227-31
pubmed: 25352562
Public Health Action. 2016 Mar 21;6(1):38-43
pubmed: 27051611
Nicotine Tob Res. 2005 Feb;7(1):149-56
pubmed: 15804687
Nicotine Tob Res. 2016 Apr;18(4):501-7
pubmed: 25895951
BMC Public Health. 2019 Apr 27;19(1):439
pubmed: 31029118
Glob Health Promot. 2010 Mar;17(1 Suppl):60-6
pubmed: 20595355
Eur Respir Rev. 2021 May 11;30(160):
pubmed: 33980668
Am J Prev Med. 2009 Dec;37(6):518-23
pubmed: 19944918
Women Health. 2012;52(1):32-54
pubmed: 22324357
Qatar Med J. 2021 Aug 10;2021(2):25
pubmed: 34405091
East Mediterr Health J. 2020 Jan 30;26(1):110-115
pubmed: 32043553
Ann Saudi Med. 2010 May-Jun;30(3):222-6
pubmed: 20427939
Int J Public Health. 2017 Jan;62(1):73-83
pubmed: 27421466
Eur J Prev Cardiol. 2012 Feb;19(1):118-25
pubmed: 21450616
Tob Control. 2015 Mar;24 Suppl 1:i60-i65
pubmed: 25550418
East Mediterr Health J. 2020 Jan 30;26(1):55-60
pubmed: 32043546
Harm Reduct J. 2013 Jul 02;10:12
pubmed: 23816366
Postgrad Med J. 2012 Oct;88(1044):566-74
pubmed: 22652700
Tob Control. 2019 Mar;28(2):181-188
pubmed: 29807946
PLoS One. 2016 Jan 08;11(1):e0146799
pubmed: 26745806
Tob Control. 2015 Mar;24 Suppl 1:i44-i53
pubmed: 25492935
Tob Control. 2008 Apr;17(2):e3
pubmed: 18375726
Heliyon. 2020 Nov 05;6(11):e05423
pubmed: 33204883
East Mediterr Health J. 2020 Jan 30;26(1):94-101
pubmed: 32043551
Int J Environ Res Public Health. 2021 Jul 19;18(14):
pubmed: 34300103
Tob Control. 2016 Mar;25(2):174-80
pubmed: 25361744
Can Respir J. 2016;2016:2684090
pubmed: 28025593
Asian Pac J Cancer Prev. 2020 Mar 01;21(3):583-591
pubmed: 32212782
Chest. 2019 Jun;155(6):1217-1225
pubmed: 30684475
Addict Behav. 2018 Dec;87:131-137
pubmed: 30016762
Int J Epidemiol. 2017 Feb 1;46(1):32-43
pubmed: 27075769
PLoS One. 2021 Apr 15;16(4):e0250065
pubmed: 33857248
Tob Induc Dis. 2021 Aug 30;19:67
pubmed: 34531711
Tob Control. 2015 Mar;24 Suppl 1:i3-i12
pubmed: 25298368
Nicotine Tob Res. 2016 Apr;18(4):395-402
pubmed: 25957438
PLoS One. 2017 Mar 8;12(3):e0171112
pubmed: 28273093
Respir Med. 2014 Sep;108(9):1241-53
pubmed: 25130679
J Environ Public Health. 2020 Nov 6;2020:2364571
pubmed: 33204280
Tob Control. 2015 Mar;24 Suppl 1:i22-i30
pubmed: 25666550
Chest. 2011 Apr;139(4):764-774
pubmed: 20671057
PLoS One. 2018 Feb 9;13(2):e0192191
pubmed: 29425207
BMJ Open. 2021 Apr 1;11(4):e044379
pubmed: 33795305
Am J Respir Crit Care Med. 2016 Sep 1;194(5):587-95
pubmed: 27007171
J Sch Health. 2008 Jun;78(6):337-43
pubmed: 18489467
Front Public Health. 2021 Aug 20;9:682355
pubmed: 34490180
Tob Induc Dis. 2020 Dec 02;18:100
pubmed: 33299390

Auteurs

Ahmad AlMulla (A)

Tobacco Control Center, WHO Collaborating Center for Treating Tobacco Dependence, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.

Silva Kouyoumjian (S)

Tobacco Control Center, WHO Collaborating Center for Treating Tobacco Dependence, Department of Medicine, Hamad Medical Corporation, Doha, Qatar.

Patrick Maisonneuve (P)

Unit of Clinical Epidemiology, Division of Epidemiology and Biostatistics, European Institute of Oncology, Scientific Institute for Research, Hospitalization and Healthcare, Milan, Italy.

Sohaila Cheema (S)

Institute for Population Health, Weill Cornell Medicine-Qatar, Doha, Qatar.

Ravinder Mamtani (R)

Institute for Population Health, Weill Cornell Medicine-Qatar, Doha, Qatar.

Classifications MeSH